0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Neglected Tropical Diseases Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-37Y3908
Home | Market Reports | Health| Public Health
Global Neglected Tropical Diseases Diagnosis Market Insights and Forecast to 2028
BUY CHAPTERS

Neglected Tropical Diseases Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37Y3908
Report
September 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neglected Tropical Diseases Diagnosis - Market Size

The global market for Neglected Tropical Diseases Diagnosis was estimated to be worth US$ 6267.3 million in 2023 and is forecast to a readjusted size of US$ 8008.3 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Neglected Tropical Diseases Diagnosis - Market

Neglected Tropical Diseases Diagnosis - Market

Neglected Tropical Diseases Diagnosis is the procedure to test if the patient have the Neglected Tropical.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neglected Tropical Diseases Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Neglected Tropical Diseases Diagnosis by region & country, by Type, and by Application.
The Neglected Tropical Diseases Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neglected Tropical Diseases Diagnosis.
Market Segmentation

Scope of Neglected Tropical Diseases Diagnosis - Market Report

Report Metric Details
Report Name Neglected Tropical Diseases Diagnosis - Market
Forecasted market size in 2030 US$ 8008.3 million
CAGR 3.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Conventional Method
  • Molecular/Modern Method
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Neglected Tropical Diseases Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Neglected Tropical Diseases Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Neglected Tropical Diseases Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Neglected Tropical Diseases Diagnosis - Market size in 2030?

Ans: The Neglected Tropical Diseases Diagnosis - Market size in 2030 will be US$ 8008.3 million.

Who are the main players in the Neglected Tropical Diseases Diagnosis - Market report?

Ans: The main players in the Neglected Tropical Diseases Diagnosis - Market are Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc.

What are the Application segmentation covered in the Neglected Tropical Diseases Diagnosis - Market report?

Ans: The Applications covered in the Neglected Tropical Diseases Diagnosis - Market report are Clinical Labs, Hospitals /Clinics, Home Healthcare

What are the Type segmentation covered in the Neglected Tropical Diseases Diagnosis - Market report?

Ans: The Types covered in the Neglected Tropical Diseases Diagnosis - Market report are Conventional Method, Molecular/Modern Method

Recommended Reports

Disease Diagnostics

Diagnostic Tools

Disease Treatments

1 Market Overview
1.1 Neglected Tropical Diseases Diagnosis Product Introduction
1.2 Global Neglected Tropical Diseases Diagnosis Market Size Forecast
1.3 Neglected Tropical Diseases Diagnosis Market Trends & Drivers
1.3.1 Neglected Tropical Diseases Diagnosis Industry Trends
1.3.2 Neglected Tropical Diseases Diagnosis Market Drivers & Opportunity
1.3.3 Neglected Tropical Diseases Diagnosis Market Challenges
1.3.4 Neglected Tropical Diseases Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neglected Tropical Diseases Diagnosis Players Revenue Ranking (2023)
2.2 Global Neglected Tropical Diseases Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Neglected Tropical Diseases Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Neglected Tropical Diseases Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Neglected Tropical Diseases Diagnosis
2.6 Neglected Tropical Diseases Diagnosis Market Competitive Analysis
2.6.1 Neglected Tropical Diseases Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Neglected Tropical Diseases Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Conventional Method
3.1.2 Molecular/Modern Method
3.2 Global Neglected Tropical Diseases Diagnosis Sales Value by Type
3.2.1 Global Neglected Tropical Diseases Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Neglected Tropical Diseases Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Neglected Tropical Diseases Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Labs
4.1.2 Hospitals /Clinics
4.1.3 Home Healthcare
4.2 Global Neglected Tropical Diseases Diagnosis Sales Value by Application
4.2.1 Global Neglected Tropical Diseases Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Neglected Tropical Diseases Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Neglected Tropical Diseases Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Neglected Tropical Diseases Diagnosis Sales Value by Region
5.1.1 Global Neglected Tropical Diseases Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Neglected Tropical Diseases Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
5.2.2 North America Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
5.3.2 Europe Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
5.5.2 South America Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value
6.3 United States
6.3.1 United States Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.3.2 United States Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.4.2 Europe Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.5.2 China Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.6.2 Japan Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Neglected Tropical Diseases Diagnosis Sales Value, 2019-2030
6.9.2 India Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Neglected Tropical Diseases Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.1.4 Abbott Laboratories Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Beckman Coulter/Danaher
7.2.1 Beckman Coulter/Danaher Profile
7.2.2 Beckman Coulter/Danaher Main Business
7.2.3 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.2.4 Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 Beckman Coulter/Danaher Recent Developments
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Bio-Rad Laboratories, Inc. Profile
7.3.2 Bio-Rad Laboratories, Inc. Main Business
7.3.3 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.3.4 Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 Life Technology Recent Developments
7.4 Life Technology
7.4.1 Life Technology Profile
7.4.2 Life Technology Main Business
7.4.3 Life Technology Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.4.4 Life Technology Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 Life Technology Recent Developments
7.5 Novartis Diagnostics., Ltd.
7.5.1 Novartis Diagnostics., Ltd. Profile
7.5.2 Novartis Diagnostics., Ltd. Main Business
7.5.3 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.5.4 Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Diagnostics., Ltd. Recent Developments
7.6 Ortho-Clinical Diagnostics
7.6.1 Ortho-Clinical Diagnostics Profile
7.6.2 Ortho-Clinical Diagnostics Main Business
7.6.3 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.6.4 Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 Ortho-Clinical Diagnostics Recent Developments
7.7 Premier Medical Corporation Ltd.
7.7.1 Premier Medical Corporation Ltd. Profile
7.7.2 Premier Medical Corporation Ltd. Main Business
7.7.3 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.7.4 Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Premier Medical Corporation Ltd. Recent Developments
7.8 Siemens Healthcare
7.8.1 Siemens Healthcare Profile
7.8.2 Siemens Healthcare Main Business
7.8.3 Siemens Healthcare Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.8.4 Siemens Healthcare Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 Siemens Healthcare Recent Developments
7.9 Wako Chemicals, Inc.
7.9.1 Wako Chemicals, Inc. Profile
7.9.2 Wako Chemicals, Inc. Main Business
7.9.3 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
7.9.4 Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 Wako Chemicals, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Neglected Tropical Diseases Diagnosis Industrial Chain
8.2 Neglected Tropical Diseases Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neglected Tropical Diseases Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Neglected Tropical Diseases Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Neglected Tropical Diseases Diagnosis Market Trends
    Table 2. Neglected Tropical Diseases Diagnosis Market Drivers & Opportunity
    Table 3. Neglected Tropical Diseases Diagnosis Market Challenges
    Table 4. Neglected Tropical Diseases Diagnosis Market Restraints
    Table 5. Global Neglected Tropical Diseases Diagnosis Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Neglected Tropical Diseases Diagnosis Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Neglected Tropical Diseases Diagnosis Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Neglected Tropical Diseases Diagnosis Product Type
    Table 9. Key Companies Time to Begin Mass Production of Neglected Tropical Diseases Diagnosis
    Table 10. Global Neglected Tropical Diseases Diagnosis Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Diagnosis as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Neglected Tropical Diseases Diagnosis Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Neglected Tropical Diseases Diagnosis Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Neglected Tropical Diseases Diagnosis Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Neglected Tropical Diseases Diagnosis Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Neglected Tropical Diseases Diagnosis Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Neglected Tropical Diseases Diagnosis Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Neglected Tropical Diseases Diagnosis Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Neglected Tropical Diseases Diagnosis Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Neglected Tropical Diseases Diagnosis Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Neglected Tropical Diseases Diagnosis Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Neglected Tropical Diseases Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2019-2024) & (%)
    Table 27. Global Neglected Tropical Diseases Diagnosis Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Beckman Coulter/Danaher Basic Information List
    Table 37. Beckman Coulter/Danaher Description and Business Overview
    Table 38. Beckman Coulter/Danaher Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Beckman Coulter/Danaher (2019-2024)
    Table 40. Beckman Coulter/Danaher Recent Developments
    Table 41. Bio-Rad Laboratories, Inc. Basic Information List
    Table 42. Bio-Rad Laboratories, Inc. Description and Business Overview
    Table 43. Bio-Rad Laboratories, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Bio-Rad Laboratories, Inc. (2019-2024)
    Table 45. Bio-Rad Laboratories, Inc. Recent Developments
    Table 46. Life Technology Basic Information List
    Table 47. Life Technology Description and Business Overview
    Table 48. Life Technology Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Life Technology (2019-2024)
    Table 50. Life Technology Recent Developments
    Table 51. Novartis Diagnostics., Ltd. Basic Information List
    Table 52. Novartis Diagnostics., Ltd. Description and Business Overview
    Table 53. Novartis Diagnostics., Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Novartis Diagnostics., Ltd. (2019-2024)
    Table 55. Novartis Diagnostics., Ltd. Recent Developments
    Table 56. Ortho-Clinical Diagnostics Basic Information List
    Table 57. Ortho-Clinical Diagnostics Description and Business Overview
    Table 58. Ortho-Clinical Diagnostics Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Ortho-Clinical Diagnostics (2019-2024)
    Table 60. Ortho-Clinical Diagnostics Recent Developments
    Table 61. Premier Medical Corporation Ltd. Basic Information List
    Table 62. Premier Medical Corporation Ltd. Description and Business Overview
    Table 63. Premier Medical Corporation Ltd. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Premier Medical Corporation Ltd. (2019-2024)
    Table 65. Premier Medical Corporation Ltd. Recent Developments
    Table 66. Siemens Healthcare Basic Information List
    Table 67. Siemens Healthcare Description and Business Overview
    Table 68. Siemens Healthcare Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Siemens Healthcare (2019-2024)
    Table 70. Siemens Healthcare Recent Developments
    Table 71. Wako Chemicals, Inc. Basic Information List
    Table 72. Wako Chemicals, Inc. Description and Business Overview
    Table 73. Wako Chemicals, Inc. Neglected Tropical Diseases Diagnosis Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Neglected Tropical Diseases Diagnosis Business of Wako Chemicals, Inc. (2019-2024)
    Table 75. Wako Chemicals, Inc. Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Neglected Tropical Diseases Diagnosis Downstream Customers
    Table 79. Neglected Tropical Diseases Diagnosis Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Neglected Tropical Diseases Diagnosis Product Picture
    Figure 2. Global Neglected Tropical Diseases Diagnosis Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 4. Neglected Tropical Diseases Diagnosis Report Years Considered
    Figure 5. Global Neglected Tropical Diseases Diagnosis Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Neglected Tropical Diseases Diagnosis Revenue in 2023
    Figure 7. Neglected Tropical Diseases Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Conventional Method Picture
    Figure 9. Molecular/Modern Method Picture
    Figure 10. Global Neglected Tropical Diseases Diagnosis Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Neglected Tropical Diseases Diagnosis Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Clinical Labs
    Figure 13. Product Picture of Hospitals /Clinics
    Figure 14. Product Picture of Home Healthcare
    Figure 15. Global Neglected Tropical Diseases Diagnosis Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Neglected Tropical Diseases Diagnosis Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Neglected Tropical Diseases Diagnosis Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Neglected Tropical Diseases Diagnosis Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Neglected Tropical Diseases Diagnosis Sales Value (%), (2019-2030)
    Figure 28. United States Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Neglected Tropical Diseases Diagnosis Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Neglected Tropical Diseases Diagnosis Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Neglected Tropical Diseases Diagnosis Sales Value by Application (%), 2023 VS 2030
    Figure 49. Neglected Tropical Diseases Diagnosis Industrial Chain
    Figure 50. Neglected Tropical Diseases Diagnosis Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS